• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测肝细胞癌预后和免疫微环境的PTEN-自噬风险模型

A PTEN-Autophagy Risk Model for the Prediction of Prognosis and Immune Microenvironment in Hepatocellular Carcinoma.

作者信息

Huang Fei, Yaermaimaiti Dilinaer, Ding Guanxin, Zhao Lijun, Zhou Jing, Wu Shunhua

机构信息

Department of Occupational and Environmental Health, School of Public Health, Xinjiang Medical University, Urumqi 830011, China.

Department of Pathology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830011, China.

出版信息

J Oncol. 2023 Feb 20;2023:2973480. doi: 10.1155/2023/2973480. eCollection 2023.

DOI:10.1155/2023/2973480
PMID:36861063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9970702/
Abstract

BACKGROUND

The clinical behavior and molecular mechanisms of hepatocellular carcinoma (HCC) are complex and highly variable, limiting the discovery of new targets and therapies in clinical research. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the tumor suppressor genes. It is of great interest to discover the role of unexplored correlation among PTEN, the tumor immune microenvironment, and autophagy-related signaling pathways and to construct a reliable risk model for prognosis during HCC progression.

METHOD

We first performed differential expression analysis on the HCC samples. By using Cox regression and LASSO analysis, we determined the DEGs contributing to the survival benefit. In addition, the gene set enrichment analysis (GSEA) was performed to identify potential molecular signaling pathways regulated by the PTEN gene signature, autophagy, and autophagy-related pathways. ESTIMATE was also employed for evaluating the composition of immune cell populations.

RESULTS

We found a significant correlation between PTEN expression and the tumor immune microenvironment. The low-PTEN expression group had higher immune infiltration and lower expression of immune checkpoints. In addition, PTEN expression was found to be positively correlated with autophagy-related pathways. Then, differentially expressed genes between tumor and tumor-adjacent samples were screened, and 2895 genes were significantly associated with both PTEN and autophagy. Based on PTEN-related genes, we identified 5 key prognostic genes, including BFSP1, PPAT, EIF5B, ASF1A, and GNA14. The 5-gene PTEN-autophagy risk score (RS) model was demonstrated to have favorable performance in the prediction of prognosis.

CONCLUSION

In summary, our study showed the importance of the PTEN gene and its correlation with immunity and autophagy in HCC. The PTEN-autophagy.RS model we established could be used to predict the prognosis of HCC patients and showed significantly higher prognostic accuracy than the TIDE score in response to immunotherapy.

摘要

背景

肝细胞癌(HCC)的临床行为和分子机制复杂且高度可变,限制了临床研究中新靶点和新疗法的发现。10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)是肿瘤抑制基因之一。探索PTEN、肿瘤免疫微环境和自噬相关信号通路之间未被发现的相关性作用,并构建一个可靠的肝癌进展预后风险模型具有重要意义。

方法

我们首先对肝癌样本进行差异表达分析。通过Cox回归和LASSO分析,确定对生存有益的差异表达基因(DEGs)。此外,进行基因集富集分析(GSEA)以识别由PTEN基因特征、自噬和自噬相关通路调控的潜在分子信号通路。还采用ESTIMATE评估免疫细胞群体的组成。

结果

我们发现PTEN表达与肿瘤免疫微环境之间存在显著相关性。PTEN低表达组具有更高的免疫浸润和更低的免疫检查点表达。此外,发现PTEN表达与自噬相关通路呈正相关。然后,筛选肿瘤与癌旁样本之间的差异表达基因,发现2895个基因与PTEN和自噬均显著相关。基于PTEN相关基因,我们鉴定出5个关键预后基因,包括BFSP1、PPAT、EIF5B、ASF1A和GNA14。5基因PTEN-自噬风险评分(RS)模型在预后预测中表现良好。

结论

总之,我们的研究表明PTEN基因及其与肝癌免疫和自噬的相关性的重要性。我们建立的PTEN-自噬.RS模型可用于预测肝癌患者的预后,并且在预测免疫治疗反应方面显示出比TIDE评分显著更高的预后准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/7266d5fc5334/JO2023-2973480.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/b50de48a5abd/JO2023-2973480.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/b74c68545624/JO2023-2973480.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/309e10e986b0/JO2023-2973480.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/4595d0a27832/JO2023-2973480.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/0928cab0c24e/JO2023-2973480.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/181f17e22f91/JO2023-2973480.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/a27e7bcdb0b2/JO2023-2973480.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/7ff65516a689/JO2023-2973480.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/7266d5fc5334/JO2023-2973480.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/b50de48a5abd/JO2023-2973480.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/b74c68545624/JO2023-2973480.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/309e10e986b0/JO2023-2973480.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/4595d0a27832/JO2023-2973480.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/0928cab0c24e/JO2023-2973480.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/181f17e22f91/JO2023-2973480.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/a27e7bcdb0b2/JO2023-2973480.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/7ff65516a689/JO2023-2973480.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c3e/9970702/7266d5fc5334/JO2023-2973480.009.jpg

相似文献

1
A PTEN-Autophagy Risk Model for the Prediction of Prognosis and Immune Microenvironment in Hepatocellular Carcinoma.一种用于预测肝细胞癌预后和免疫微环境的PTEN-自噬风险模型
J Oncol. 2023 Feb 20;2023:2973480. doi: 10.1155/2023/2973480. eCollection 2023.
2
Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.鉴定调控肝癌肿瘤免疫微环境和预后的 COVID-19 关键基因。
Funct Integr Genomics. 2023 Aug 4;23(3):262. doi: 10.1007/s10142-023-01184-z.
3
Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma.肝细胞癌中关键基因与免疫浸润水平和肿瘤突变负荷的联合探索。
Comb Chem High Throughput Screen. 2024;27(14):2110-2124. doi: 10.2174/0113862073239916231023053142.
4
PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma.用于预测肝细胞癌预后和免疫治疗反应的PTEN相关风险分类模型
Discov Oncol. 2023 Jul 20;14(1):134. doi: 10.1007/s12672-023-00743-x.
5
Comprehensive Bioinformatic Analysis Reveals an Autophagy-related Gene Signature for Predicting Outcome, Immune Status, and Drug Sensitivity in Hepatocellular Carcinoma.综合生物信息学分析揭示了一种与自噬相关的基因特征,用于预测肝细胞癌的预后、免疫状态和药物敏感性。
Recent Pat Anticancer Drug Discov. 2024 Jan 9. doi: 10.2174/0115748928275025231213103658.
6
A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.一种包含脂质代谢和免疫相关基因的新型特征,用于预测肝细胞癌的预后和免疫格局。
Front Oncol. 2023 Jun 6;13:1182434. doi: 10.3389/fonc.2023.1182434. eCollection 2023.
7
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.一种新型肝细胞癌免疫相关预后模型的开发与验证
J Transl Med. 2020 Feb 11;18(1):67. doi: 10.1186/s12967-020-02255-6.
8
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.铜死亡相关特征可预测肝细胞癌的预后、肿瘤微环境和药物敏感性。
J Immunol Res. 2022 Nov 16;2022:3393027. doi: 10.1155/2022/3393027. eCollection 2022.
9
Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma.肝细胞癌免疫相关基因特征的鉴定与分析。
Genes (Basel). 2022 Oct 11;13(10):1834. doi: 10.3390/genes13101834.
10
Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.鉴定免疫浸润相关基因作为肝细胞癌的预后指标。
BMC Cancer. 2022 May 5;22(1):496. doi: 10.1186/s12885-022-09587-0.

引用本文的文献

1
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines.基于自噬的肝细胞癌治疗:从标准治疗到联合治疗、溶瘤病毒疗法和靶向纳米药物。
Clin Exp Med. 2024 Dec 2;25(1):13. doi: 10.1007/s10238-024-01527-5.

本文引用的文献

1
Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.Sangerbox:一个全面的、用户交互友好的临床生物信息学分析平台。
Imeta. 2022 Jul 8;1(3):e36. doi: 10.1002/imt2.36. eCollection 2022 Sep.
2
A damage-associated molecular patterns-related gene signature for the prediction of prognosis and immune microenvironment in children stage III acute lymphoblastic leukemia.一种与损伤相关分子模式相关的基因特征,用于预测儿童III期急性淋巴细胞白血病的预后和免疫微环境。
Front Pediatr. 2022 Oct 20;10:999684. doi: 10.3389/fped.2022.999684. eCollection 2022.
3
ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.
ASF1B在肺腺癌及其他癌症类型中促进肿瘤发生。
Front Oncol. 2021 Sep 9;11:731547. doi: 10.3389/fonc.2021.731547. eCollection 2021.
4
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.真核生物翻译起始因子5B(eIF5B)通过与Wig1相互作用来调节前列腺癌细胞中程序性死亡受体配体1(PD-L1)的表达。
BMC Cancer. 2021 Sep 15;21(1):1022. doi: 10.1186/s12885-021-08749-w.
5
Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.泛癌综合分析揭示 ASF1B 作为预后和免疫生物标志物的潜力。
Cancer Med. 2021 Oct;10(19):6897-6916. doi: 10.1002/cam4.4203. Epub 2021 Sep 2.
6
The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types.基因组序列档案家族:走向爆炸式的数据增长和多样化的数据类型。
Genomics Proteomics Bioinformatics. 2021 Aug;19(4):578-583. doi: 10.1016/j.gpb.2021.08.001. Epub 2021 Aug 13.
7
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.针对人类癌症的靶向治疗,攻击 PI3K/Akt/mTOR 信号通路。
Semin Cancer Biol. 2022 Oct;85:69-94. doi: 10.1016/j.semcancer.2021.06.019. Epub 2021 Jun 25.
8
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer.eIF5B 驱动肺癌中 PD-L1 的应激反应依赖的翻译。
Nat Cancer. 2020 May;1(5):533-545. doi: 10.1038/s43018-020-0056-0. Epub 2020 Apr 20.
9
The Tumor Suppressor as Molecular Switch Node Regulating Cell Metabolism and Autophagy: Implications in Immune System and Tumor Microenvironment.肿瘤抑制因子作为调节细胞代谢和自噬的分子开关节点:在免疫系统和肿瘤微环境中的意义。
Cells. 2020 Jul 18;9(7):1725. doi: 10.3390/cells9071725.
10
Immune checkpoint signaling and cancer immunotherapy.免疫检查点信号与癌症免疫治疗。
Cell Res. 2020 Aug;30(8):660-669. doi: 10.1038/s41422-020-0343-4. Epub 2020 May 28.